Live from the NIH registry
Studies recruiting near Santa Maria right now
Top 25 of 93 recruiting studies, sorted by proximity — each links to its official registry page
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Access Community Clinical Trials — Mission Hills, California (17.1 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
Effectiveness of the SoundHeal Multi-Sensory Integrative Therapy Among Justice-Involved Youth
Emotional Dysregulation, Therapeutic Alliance
N/A
Interventional 12 participants sought
San Luis Obispo County Juvenile Hall — San Luis Obispo, California (27.1 mi)
· Sponsor: SoundHeal
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: NRG Oncology
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Santa Maria, California (1.4 mi)
· Sponsor: AstraZeneca
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Heart Failure
Phase 2
Interventional 620 participants sought
Comprehensive Cardiovascular Care — Santa Maria, California (1.4 mi)
· Sponsor: Pfizer
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
PCR Oncology — Arroyo Grande, California (15.3 mi)
· Sponsor: NRG Oncology
Adherence to Different Exercise Interventions
Exercise Adherence
N/A
Interventional 60 participants sought
California Polytechnic State University — San Luis Obispo, California (27.1 mi)
· Sponsor: California Polytechnic State University-San Luis Obispo
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Santa Maria, California (1.4 mi)
· Sponsor: Akero Therapeutics, Inc
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Phase 3
Interventional 840 participants sought
Research Site — Solvang, California (29.1 mi)
· Sponsor: AstraZeneca
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma, Metastatic Gastric Cancer
Phase 2, Phase 3
Interventional 840 participants sought
UCLA Hematology/Oncology - San Luis Obispo — San Luis Obispo, California (27.1 mi)
· Sponsor: Pfizer
Sleep Well Firefighters: An App-based Program to Improve Sleep, Cognition, and Behavioral Health in Firefighters
Sleep Health, Stress
N/A
Interventional 50 participants sought
California Polytechnic University - San Luis Obispo — San Luis Obispo, California (27.1 mi)
· Sponsor: California Polytechnic State University-San Luis Obispo
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: SWOG Cancer Research Network
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: SWOG Cancer Research Network
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
N/A
Interventional 535 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Lipoprotein Disorder
Phase 2
Interventional 204 participants sought
FOMAT - Comprehensive Cardiovascular Care-Santa Maria California — Santa Maria, California (1.4 mi)
· Sponsor: Kylonova (Xiamen) Biopharma co., LTD.
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Cardiovascular Health
N/A
Interventional 6,618 participants sought
California Polytechnic State University — San Luis Obispo, California (27.1 mi)
· Sponsor: JHSPH Center for Clinical Trials
Multi-analyte Blood Test Clinical Trial
Liver Cirrhosis, Liver Cancer
N/A
Observational 1,200 participants sought
Providence Facey Medical Foundation — Mission Hills, California (17.1 mi)
· Sponsor: Helio Genomics
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Ovarian Cancer
Phase 2
Interventional 400 participants sought
Sansum Clinic - Solvang /ID# 277712 — Solvang, California (29.1 mi)
· Sponsor: AbbVie
Family Communications After Genetic Testing
Colon Adenocarcinoma, Colorectal Adenocarcinoma
N/A
Interventional 4,186 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma
Phase 2
Interventional 152 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Fomat Medical Research — Santa Maria, California (1.4 mi)
· Sponsor: Novo Nordisk A/S